Ares Management (ARES) Jumps 3.7% with High Volume

After this afternoon's 3.7% surge to $100.27 per share, Ares Management might just keep moving past its target price of $100.73. With an average analyst rating of buy, and target prices from $89.0 to $111.0, the stock's next move is anyone's guess.

The stock has an average amount of shares sold short at 3.5%, and a short ratio of 3.99. The company's insiders own 18.07% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 76.2% of Ares Management's shares being owned by this investor type.

Institutions Invested in Ares Management

Date Reported Holder Percentage Shares Value
2023-03-31 Wellington Management Group, LLP 10% 17,634,391 $1,768,200,326
2023-03-31 Vanguard Group, Inc. (The) 8% 14,977,336 $1,501,777,430
2023-03-31 Sumitomo Mitsui Financial Group, Inc. 7% 13,364,740 $1,340,082,434
2023-03-31 Blackrock Inc. 6% 10,618,459 $1,064,712,848
2023-03-31 Capital World Investors 6% 10,060,448 $1,008,761,087
2023-03-31 Capital International Investors 4% 6,585,110 $660,288,957
2023-03-31 HMI Capital Management, LP 2% 3,818,853 $382,916,377
2023-03-31 Boston Partners 2% 3,211,852 $322,052,389
2023-03-31 Franklin Resources, Inc. 2% 3,176,937 $318,551,462
2023-03-31 State Street Corporation 2% 3,002,715 $301,082,222

Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Ares Management.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS